Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation

被引:265
作者
McDiarmid, SV
Anand, R
Lindblad, AS
机构
[1] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA
[2] EMMES Corp, Rockville, MD USA
关键词
D O I
10.1097/00007890-200207270-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A pediatric end-stage liver disease (PELD) score for children with chronic liver disease using easily obtainable, objective, verifiable parameters, would be useful to prioritize children awaiting liver transplantation. Methods. Data from the Studies of Pediatric Liver Transplantation (SPLIT), a consortium of 29 U.S. and Canadian centers, were used to develop the PELD score. Two pretransplantation endpoints were evaluated: (1) death, n=884; and (2) death or moving to the intensive care unit (ICU), n=779. The analyses were restricted to children with chronic liver disease who were listed for a first transplant. Preliminary analyses of 17 possible factors yielded 6 parameters of interest: age < 1 year, total bilirubin, international normalized ratio (INR), albumin, growth failure (height or weight Z score < -2), and calculated glomerular filtration rate. In a univariate Cox regression analysis, age, bilirubin, INR, and albumin were significant (P < 0.01) predictors of both endpoints; glomerular filtration rate was not significant for either endpoint; and growth failure was significant for death/ICU but not death alone. In the multivariate analyses, age, bilirubin, and INR were significant for the death endpoint; and bilirubin, INR, growth failure, and albumin were significant for the death/ICU endpoint. From these results, three PELD models were evaluated to predict both outcomes at 3 and 6 months: PELD I (age, bilirubin, INR); PELD 2 (bilirubin, INR, albumin, growth failure); and PELD 3 (bilirubin, INR, albumin, growth failure, and age). The area under the receiver operating characteristic curve (AUC ROC) was used to compare models. For PELD 3, the most inclusive model, the AUC ROC at 3 months was 0.92 for death and 0.82 for, "death-moved to ICU." A comparison of the AUC ROCs for the other models and for the model of end-stage liver disease ([MELD], the adult end-stage liver disease severity score model), none of which performed better than PELD 3, are presented. Conclusion. A model using five objective parameters can accurately predict death or death-moved to ICU in children awaiting liver transplantation.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 24 条
  • [1] Belle S H, 1995, Clin Transpl, P19
  • [2] Liver transplantation in infants younger than 1 year of age
    Colombani, PM
    Cigarroa, FG
    Schwarz, K
    Wise, B
    Maley, WE
    Klein, AS
    [J]. ANNALS OF SURGERY, 1996, 223 (06) : 658 - 662
  • [3] RENAL-FAILURE IN CHILDREN WITH HEPATIC-FAILURE UNDERGOING LIVER-TRANSPLANTATION
    ELLIS, D
    AVNER, ED
    STARZL, TE
    [J]. JOURNAL OF PEDIATRICS, 1986, 108 (03) : 393 - 398
  • [4] Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time
    Freeman, RB
    Rohrer, RJ
    Katz, E
    Lewis, WD
    Jenkins, R
    Cosimi, AB
    Delmonico, F
    Friedman, A
    Lorber, M
    O'Connor, K
    Bradley, J
    [J]. LIVER TRANSPLANTATION, 2001, 7 (03) : 173 - 178
  • [5] Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy
    Freeman, RB
    Edwards, EB
    [J]. LIVER TRANSPLANTATION, 2000, 6 (05) : 543 - 552
  • [6] Long-term results of pediatric liver transplantation - An analysis of 569 transplants
    Goss, JA
    Shackleton, CR
    McDiarmid, SV
    Maggard, M
    Swenson, K
    Seu, P
    Vargas, J
    Martin, M
    Ament, M
    Brill, J
    Harrison, R
    Busuttil, RW
    [J]. ANNALS OF SURGERY, 1998, 228 (03) : 411 - 419
  • [7] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    [J]. HEPATOLOGY, 2001, 33 (02) : 464 - 470
  • [8] Kane R, 2001, TRANSPLANTATION, V72, P463
  • [9] KIM WR, 2001, AM SOC TRANSPLANT PH, V1, P283
  • [10] Lucey M R, 1997, Liver Transpl Surg, V3, P628